Chi‐Yuan Yao

478 total citations
38 papers, 253 citations indexed

About

Chi‐Yuan Yao is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Chi‐Yuan Yao has authored 38 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 18 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Chi‐Yuan Yao's work include Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Cancer Genomics and Diagnostics (5 papers). Chi‐Yuan Yao is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Cancer Genomics and Diagnostics (5 papers). Chi‐Yuan Yao collaborates with scholars based in Taiwan, United States and United Kingdom. Chi‐Yuan Yao's co-authors include Hwei‐Fang Tien, Wen‐Chien Chou, Chien‐Chin Lin, Hsin‐An Hou, Cheng‐Hong Tsai, Chia‐Lang Hsu, Laura Simon, Jean-François Spinella, Marie-Ève Bordeleau and Sébastien Lemieux and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Chi‐Yuan Yao

31 papers receiving 249 citations

Peers

Countries citing papers authored by Chi‐Yuan Yao

Since Specialization

Citations

This map shows the geographic impact of Chi‐Yuan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Yuan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Yuan Yao more than expected).

Fields of papers citing papers by Chi‐Yuan Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Yuan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Yuan Yao. The network helps show where Chi‐Yuan Yao may publish in the future.

Co-authorship network of co-authors of Chi‐Yuan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Yuan Yao. A scholar is included among the top collaborators of Chi‐Yuan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Yuan Yao. Chi‐Yuan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clonal Hematopoiesis Is Associated With Adverse Clinical Outcomes and Left Ventricular Remodeling in Aortic Stenosis 2025 ·JACC Advances ·Chi‐Yuan Yao, (unknown), Li‐Tan Yang, Masaaki Takeuchi, (unknown), Mao-Shin Lin, Ying‐Hsien Chen, Ching‐Ying Kuo, Chia‐Lang Hsu, Wen‐Chien Chou, Hsien‐Li Kao	1
2	Inhibition of DOCK1 suppresses Notch signalling pathway and impairs leukaemogenesis 2025 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Chi‐Yuan Yao, (unknown), (unknown), Chang‐Tsu Yuan, Chia‐Lang Hsu, (unknown), Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	0
3	IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo 2024 ·SHILAP Revista de lepidopterología ·Chien‐Chin Lin, Chi‐Yuan Yao, (unknown), (unknown), Chang‐Tsu Yuan, (unknown), Chia‐Lang Hsu, (unknown), (unknown), (unknown), (unknown), (unknown), Yuan‐Yeh Kuo, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	0
4	Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations 2024 ·Blood Cancer Journal ·Feng‐Ming Tien, Chi‐Yuan Yao, Cheng‐Hong Tsai, (unknown), Chien‐Yuan Chen, (unknown), Chien‐Chin Lin, Yuan‐Yeh Kuo, Yen‐Ling Peng, Mei‐Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang‐In Lin, (unknown), Bor‐Sheng Ko, Ming Yao, Jih‐Luh Tang, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	8
5	Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes 2024 ·Blood Advances ·Chi‐Yuan Yao, Chien‐Chin Lin, (unknown), (unknown), Cheng‐Hong Tsai, Hsin‐An Hou, (unknown), Chia‐Lang Hsu, Wen‐Chien Chou	3
6	Stellae-123 gene expression signature improved risk stratification in Taiwanese acute myeloid leukemia patients 2024 ·Scientific Reports ·(unknown), Adrián Mosquera Orgueira, Chien‐Chin Lin, Chi‐Yuan Yao, (unknown), Cheng‐Hong Tsai, (unknown), Hsin‐An Hou, Wen‐Chien Chou, (unknown)	1
7	A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia 2023 ·British Journal of Haematology ·(unknown), Chi‐Yuan Yao, Chien‐Chin Lin, (unknown), Fabio M. R. Amaral, (unknown), Andrés Jerez, Tim C. P. Somervaille, Moritz Binder, Mrinal M. Patnaik, Hsin‐An Hou, Wen‐Chien Chou, Kiran Batta, Daniel H. Wiseman, Hwei‐Fang Tien	2
8	Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target 2023 ·Leukemia ·(unknown), Chien‐Chin Lin, (unknown), Bettina Wingelhofer, Fabio M. R. Amaral, Chi‐Yuan Yao, (unknown), (unknown), Hsin‐An Hou, Wen‐Chien Chou, Kiran Batta, Daniel H. Wiseman, Hwei‐Fang Tien	1
9	High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes 2023 ·Blood Advances ·(unknown), Chien‐Chin Lin, Chi‐Yuan Yao, Fabio M. R. Amaral, (unknown), (unknown), (unknown), Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	7
10	A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia 2023 ·SHILAP Revista de lepidopterología ·(unknown), Chi‐Yuan Yao, Feng‐Ming Tien, Chien‐Chin Lin	1
11	Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy 2023 ·Journal of Hematopathology ·(unknown), (unknown), Ching Li, (unknown), (unknown), (unknown), Yu‐Jung Liu, Szu-Chun Hsu, Chi‐Yuan Yao, (unknown), Chien‐Chin Lin, Hwei‐Fang Tien, Wen‐Chien Chou	3
12	Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair 2022 ·Oncogene ·(unknown), Chi‐Yuan Yao, Yuren Chen, Chang‐Tsu Yuan, Chien‐Chin Lin, (unknown), (unknown), (unknown), (unknown), Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	6
13	Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia 2022 ·Molecular Cancer Research ·(unknown), Hsin‐Yi Wu, Shang‐Ju Wu, (unknown), (unknown), Kuen‐Tyng Lin, Liang‐In Lin, Chi‐Yuan Yao, (unknown), (unknown), Takashi Angata, Hwei‐Fang Tien, Yu‐Ju Chen, Kuo‐I Lin	0
14	The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression 2022 ·Journal of the Formosan Medical Association ·Chi‐Yuan Yao, Chien‐Chin Lin, (unknown), Chia‐Lang Hsu, (unknown), Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	1
15	Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis 2022 ·Annals of Hematology ·(unknown), Chi‐Yuan Yao, (unknown), Chien‐Ting Lin, Marcus J. Calkins, Yuan‐Yeh Kuo, Jih‐Luh Tang, Hwei‐Fang Tien, Shang‐Ju Wu	5
16	Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients 2022 ·SHILAP Revista de lepidopterología ·(unknown), Chi‐Yuan Yao, Chien‐Chin Lin, Chi‐Ling Chen, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	4
17	Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome 2021 ·British Journal of Haematology ·(unknown), Chien‐Chin Lin, Chi‐Yuan Yao, Chia‐Lang Hsu, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	3
18	Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice 2020 ·Oncogene ·Chien‐Chin Lin, Chi‐Yuan Yao, (unknown), Hsin‐An Hou, Chang‐Tsu Yuan, (unknown), (unknown), (unknown), Yu‐Chiao Chiu, Yidong Chen, Wen‐Chien Chou, Hwei‐Fang Tien	16
19	Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 2020 ·Annals of Hematology ·(unknown), Chien‐Chin Lin, Chia‐Lang Hsu, (unknown), Chi‐Yuan Yao, (unknown), Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien	24
20	Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients 2019 ·EBioMedicine ·Cheng‐Hong Tsai, Chi‐Yuan Yao, (unknown), Jih‐Luh Tang, Yuan‐Yeh Kuo, Yu‐Chiao Chiu, Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact